Abstract
Irène Buvat, PhD, Centre National de la Recherche Scientifique (CNRS) director of research and head of the Inserm Laboratory of Translational Imaging in Oncology at the Institut Curie (Orsay, France), and Ken Herrmann, MD, MBA, professor and chair, Department of Nuclear Medicine at the Universitä
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
